Termination of Consulting Agreement between Momenta Pharmaceuticals, Inc. and Bennett M. Shapiro

Summary

Momenta Pharmaceuticals, Inc. and Bennett M. Shapiro have mutually agreed to end their Consulting Agreement, originally dated October 4, 2004, effective March 30, 2007. Despite the termination, the agreement specifies that provisions related to developments and confidentiality will continue to apply after the end date. Both parties have signed to confirm their acceptance of these terms.

EX-10.1 2 a07-10861_1ex10d1.htm EX-10.1

Exhibit 10.1

TERMINATION OF
CONSULTING AGREEMENT

Reference is made to the Consulting Agreement dated October 4, 2004 between MOMENTA PHARMACEUTICALS, INC., (the “Company”) and Bennett M. Shapiro (“Consultant”), as amended (collectively, the “Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings given such terms in the Agreement.

The parties hereby agree to terminate Agreement effective as of March 30, 2007. Notwithstanding anything to the contrary, Sections 3 (Developments) and 4 (Confidentiality) shall survive such termination.

Agreed to as of the date of last signature below.

CONSULTANT	MOMENTA PHARMACEUTICALS, INC.
/s/ Bennett M. Shapiro	By:	/s/ Craig A. Wheeler
Bennett M. Shapiro	Print Name: Craig A. Wheeler
Date:	Title: President & CEO
	Date: March 30, 2007